Lv21
108 积分 2024-07-16 加入
First-in-human study on tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of XKH001, a recombinant humanized monoclonal antibody against IL-25 in healthy Chinese volunteers
2个月前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
3个月前
已完结
CAR immune cells: design principles, resistance and the next generation
6个月前
已完结
Recent advances and current challenges in CAR-T cell therapy
6个月前
已完结
EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies
7个月前
已完结
CAR T-cell therapy in autoimmune diseases
8个月前
已完结
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
10个月前
已完结
Trends in the drug target landscape for autoimmune diseases
11个月前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
11个月前
已完结
皖公网安备34019202002308
